SCHEMBL2926313

SCHEMBL2926313

O=C(Nc1ccc2nc(CN3CCN=C3Cc3ccccc3)ccc2c1)c1ccc(-c2ccc(F)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 9/20 0.64
HTR2C P28335 8/20 0.64
HDAC6 Q9UBN7 2/20 0.42
FAAH O00519 1/20 0.42
MAPT P10636 2/20 0.42
PLAU P00749 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ATM Q13315 1/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2926412 0.92 MCHR1 (0.53) MCHR1HTR2CHDAC6FAAHMAPT
SCHEMBL2927111 0.87 MCHR1 (0.67) MCHR1HTR2CFAAHMAPTPLAU
SCHEMBL2926503 0.85 MCHR1 (0.70) MCHR1HTR2CMAPTNPC1RAB9A
SCHEMBL2926349 0.83 MCHR1 (0.59) MCHR1HTR2CFAAHMAPTPLAU
SCHEMBL2920512 0.82 MCHR1 (0.58) MCHR1HTR2CPLAUNPC1RAB9A
SCHEMBL2924502 0.79 MCHR1 (0.55) MCHR1HTR2CFAAHPLAUNPC1
SCHEMBL2927594 0.79 MCHR1 (1.00) MCHR1HTR2CFAAHMAPTKDM4E
SCHEMBL2926869 0.78 MCHR1 (0.98) MCHR1HTR2CFAAHMAPTADORA2A
SCHEMBL13177222 0.77 HTR2C (0.73) MCHR1HTR2CFAAHMAPTNPC1
SCHEMBL2921735 0.76 MCHR1 (0.84) MCHR1HTR2CFAAHNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1285651-B1 MELANIN CONCENTRATING HORMONE ANTAGONISTS TAKEDA PHARMACEUTICAL (JP) 2010-09-01 EP disclosed
US-6930185-B2 Melanin-concentrating hormone antagonist TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-08-16 US disclosed
US-20040077628-A1 Melanin-concentrating hormone antagonist TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-04-22 US disclosed
EP-1285651-A1 MELANIN CONCENTRATING HORMONE ANTAGONISTS Takeda Chemical Industries, Ltd. (JP) 2003-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077628-A1 Melanin-concentrating hormone antagonist MCHR1, MC1R, MCHR2 MCHR1 1/4885HTR2C 107/4885HDAC6 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.